Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2003
09/23/2003US6623940 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
09/23/2003US6623938 Human I-FLICE (Inhibitor of FLICE (FADD-like ICE)) polynucleotides; vectors, host cells and recombinant methods for producing the same
09/23/2003US6623934 For isolation of proteins that may be used to induce bone and/or cartilage or other connective tissue formation, and in wound healing and tissue repair
09/23/2003US6623925 Screening for a test compound that affects the ability of DNA to bind to protein or affects the expression of reporter molecule; use for gene therapy
09/23/2003US6623749 Medical device containing polyhydroxyalkanoate treated with oxidizing agent to remove endotoxin
09/23/2003US6623738 Polypeptide consisting of amino acid sequence 2 or 4 which is not cross reactive with mouse, chick nor drosophila neuro-pilin-1
09/23/2003US6623733 Harvesting tissue cells; lysing and filtering; administering angiogenic filtrate
09/18/2003WO2003076950A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
09/18/2003WO2003076631A2 Genetic products differentially expressed in tumors and use thereof
09/18/2003WO2003076626A1 Gene participating in the synthesis of brassinosteroid
09/18/2003WO2003076619A1 Modified gene-silencing rna and uses thereof
09/18/2003WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene
09/18/2003WO2003076616A1 Dna encoding lactate dehydrogenase and utilization thereof
09/18/2003WO2003076613A1 Protein sustaining undifferentiated stem cells as such
09/18/2003WO2003076610A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003WO2003076604A2 Surgical device for skin therapy or testing
09/18/2003WO2003076603A2 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
09/18/2003WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
09/18/2003WO2003076601A1 Avian cell lines for the production of useful substances
09/18/2003WO2003076600A2 In vitro maturation of immature human oocytes
09/18/2003WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003WO2003076564A2 Tissue-engineered organs
09/18/2003WO2003076475A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
09/18/2003WO2003076473A1 Specific ab1'-antibodies against tumour-associated antigen ca 125
09/18/2003WO2003076472A2 Neoplasm specific antibodies and uses thereof
09/18/2003WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/18/2003WO2003076462A1 Use of recombinant trypsin for vaccine production
09/18/2003WO2003075953A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies
09/18/2003WO2003075945A2 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
09/18/2003WO2003075856A2 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
09/18/2003WO2003075840A2 Human antibodies specific to kdr and uses thereof
09/18/2003WO2003075831A2 NOVEL p53BP2 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME
09/18/2003WO2003075790A2 Gas-plasma treatment of implants
09/18/2003WO2003075747A2 Contrast agents for magnetic resonance imaging and methods related thereto
09/18/2003WO2003075669A2 Food fermentation with lactic acid bacteria
09/18/2003WO2003075655A2 Novel vip3 toxins and methods of use
09/18/2003WO2003075648A1 Method of producing cell lines
09/18/2003WO2003060068A3 Oxa1p enhanced protein secretion
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
09/18/2003WO2003054159A3 Modulating insulin receptor signaling through targeting facl
09/18/2003WO2003050247A3 Antisense modulation of mhc class ii transactivator expression
09/18/2003WO2003048735A3 Processes for the measurement of the potency of glatiramer acetate
09/18/2003WO2003038082A3 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants
09/18/2003WO2003035861A3 Thrombin-cleavable chimeric proteins
09/18/2003WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
09/18/2003WO2003025191A3 Pseudotyped retroviral vector system
09/18/2003WO2003024472A3 Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof
09/18/2003WO2003018782A3 Differentiation of neural stem cells and therapeutic use theeof
09/18/2003WO2003012060A9 Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd
09/18/2003WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
09/18/2003WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
09/18/2003WO2002077174A3 Human cytokine receptor
09/18/2003WO2002072790A3 Tsg101-gag interaction and use thereof
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease
09/18/2003WO2002036625A9 Prokineticin polypeptides, related compositions and methods
09/18/2003US20030177546 Genetic engineered plant; uniform particles
09/18/2003US20030177545 Inbred corn line G0302
09/18/2003US20030177544 Genetic engineered plant; uniform particles
09/18/2003US20030177543 Genetic engineered plant; uniform particles
09/18/2003US20030177542 Inbred corn line G2202
09/18/2003US20030177541 Produced by crossing the inbred corn plant 5750 with itself or with another corn plant, such as another inbred
09/18/2003US20030177540 Prevention diseases; genetic engineering
09/18/2003US20030177539 Genetic engineering; fungi tolerance; chemical resistance
09/18/2003US20030177536 Transgenic plant; genetic engineering
09/18/2003US20030177535 Genes for altering mitochondrial function and for hybrid seed production
09/18/2003US20030177533 Variants of ADP-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
09/18/2003US20030177532 Manipulation of starch granule size and number
09/18/2003US20030177527 Nucleotide sequences coding signal transduction components in durable and broad-range resistance strategies based on plant defence
09/18/2003US20030177522 Genetic engineering; hybrids; transformated plants, seeds
09/18/2003US20030177518 Plant gene
09/18/2003US20030177516 Gut-specific gene expression in transgenic avians
09/18/2003US20030177514 UBE2G2 ubiquitin-conjugating enzyme gene disruptions, compositions and methods related thereto
09/18/2003US20030177512 Interference with coding sequence of target genes; transgenic animals; insertion of stem cell into embryo
09/18/2003US20030177511 Antitumor, anticancer agents
09/18/2003US20030177509 Mouse model for HIV infection utilizing a chimeric HIV/MLV Gag protein that permits efficient assembly from murine cells
09/18/2003US20030177508 Elongase genes and uses thereof
09/18/2003US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176679 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
09/18/2003US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna
09/18/2003US20030176674 Vascular endothelial growth factor 2
09/18/2003US20030176667 Transfroming growth factor; drug design
09/18/2003US20030176666 Hypothalamus-specific polypeptides
09/18/2003US20030176659 Adipocyte-specific protein homologs
09/18/2003US20030176658 Adipocyte-specific protein homologs
09/18/2003US20030176653 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/18/2003US20030176652 Human and mouse beta-defensins, antimicrobial peptides
09/18/2003US20030176651 Multiprotein-complex comprising a nmda receptor and uses thereof
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176649 Genetic engineering; cardiovascular disorders; antiischemic agents; antitumor agents; vision disorders; antiarthritic agents
09/18/2003US20030176648 Ion channel
09/18/2003US20030176647 Antibodies to OCIF-binding molecules
09/18/2003US20030176644 Compositions and methods for molecular biology
09/18/2003US20030176638 Liquid phase complexing with a polymer
09/18/2003US20030176389 Administering to a subject suffering from gastrointestinal inflammation a formulation comprising an immunomodulatory nucleic acid to the subject, the immunomodulatory nucleic acid comprising the sequence 5'-CpG-3'
09/18/2003US20030176388 Fatty acid synthase mRNA binding protein
09/18/2003US20030176387 Regulation of human pyroglutamyl peptidase-like enzyme
09/18/2003US20030176383 Antisense modulation of p38 mitogen activated protein kinase expression